CITIC Private Equity is to exit from Beijing Jialin Pharmaceutical Co., Ltd. through a trade sale. It will sell its 10.26% stake to Yantai, Shandong province-based Chinese drug-maker Luye Pharma Group for RMB589 million (US$95.88 million), according to an announcement made by Luye. Luye will invest a total of RMB3.68 billion (US$600 million) to take […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.